VALGANCICLOVIR and DEATH

Overview

DEATH is the #9 most commonly reported adverse reaction for VALGANCICLOVIR, manufactured by H2-Pharma, LLC. There are 753 FDA adverse event reports linking VALGANCICLOVIR to DEATH. This represents approximately 2.1% of all 36,658 adverse event reports for this drug.

Patients taking VALGANCICLOVIR who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEATH is a less commonly reported adverse event for VALGANCICLOVIR, but still significant enough to appear in the safety profile.

Other Side Effects of VALGANCICLOVIR

In addition to death, the following adverse reactions have been reported for VALGANCICLOVIR:

• OFF LABEL USE — 2,858 reports
• CYTOMEGALOVIRUS INFECTION — 1,756 reports
• DRUG INEFFECTIVE — 1,426 reports
• NEUTROPENIA — 1,096 reports
• PYREXIA — 940 reports
• DIARRHOEA — 916 reports
• LEUKOPENIA — 914 reports
• ACUTE KIDNEY INJURY — 797 reports
• CYTOMEGALOVIRUS VIRAEMIA — 722 reports
• PANCYTOPENIA — 662 reports

Other Drugs Associated with DEATH

The following drugs have also been linked to death in FDA adverse event reports:

Does VALGANCICLOVIR cause DEATH?

DEATH has been reported as an adverse event in 753 FDA reports for VALGANCICLOVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEATH with VALGANCICLOVIR?

DEATH accounts for approximately 2.1% of all adverse event reports for VALGANCICLOVIR, making it a notable side effect.

What should I do if I experience DEATH while taking VALGANCICLOVIR?

If you experience death while taking VALGANCICLOVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages